Skip to main content

Table 2 Clinical condition of patients

From: Current utilization and influencing factors of complementary and alternative medicine among children with neuropsychiatric disease: a cross-sectional survey in Korea

Variable Overall CAM P value
Current user (with or without other rehabilitation therapies) Non-user with other rehabilitation therapies Non-user without other rehabilitation therapies
Primary Diagnosis      
 Epilepsy 389 (67.3) 85 (77.3) 101 (50.5) 203 (75.7) <0.0001
 CP 56 (9.7) 9 (8.2) 41 (20.5) 6 (2.3)  
 Developmental disordera 51 (8.8) 6 (5.5) 27 (13.5) 18 (6.7)  
 ADHD 43 (7.4) 7 (6.4) 11 (5.5) 25 (9.3)  
 Others 39 (6.7) 3 (2.7) 20 (10.0) 16 (6.0)  
Disease Duration (mos)      
 Mean ± SD 62.1 ± 47.6 65.5 ± 43.9ab 68.3 ± 46.5a 55.5 ± 49.4b 0.015
 Median (range) 48 (0–229) 57 (1–211) 55 (0–229) 38 (0–226)  
Disease Duration      
  < 48 months 137 (33.9) 20 (25.6) 37 (24.2) 80 (46.2) <0.0001
  ≥ 48 months 267 (66.1) 58 (74.4) 116 (75.8) 93 (53.8)  
Having Health Problems      
 Yes 341 (59.0) 67 (60.9) 132 (66.0) 142 (53.0) 0.016
 No 237 (41.0) 43 (39.1) 68 (34.0) 126 (47.0)  
Number of Health Problems      
 Mean ± SD 0.8 ± 0.9 0.9 ± 0.9ab 0.9 ± 0.9a 0.7 ± 0.8b 0.007
 Median (range) 1 (0–5) 1 (0–4) 1 (0–5) 1 (0–4)  
Health Problems      
 Atopic dermatitis 60 (10.4) 10 (9.1) 20 (10.0) 30 (11.2) 0.81
 Allergic rhinitis 103 (17.8) 21 (19.1) 27 (13.5) 55 (20.5) 0.14
 Asthma 19 (3.3) 1 (0.9) 9 (4.5) 9 (3.4) 0.34
 Dyspepsia 40 (0.9) 8 (7.3) 16 (8.0) 16 (6.0) 0.68
 Growth retardation 86 (14.9) 22 (20.0) 45 (22.5) 19 (7.7) <0.0001
 Enuresis 13 (2.2) 2 (1.8) 7 (3.5) 4 (1.5) 0.33
 Frequent URI 125 (21.6) 30 (27.3) 51 (25.5) 44 (16.4) 0.017
 Others 23 (4.0) 3 (2.7) 12 (6.0) 8 (3.0) 0.19
  1. aDevelopmental disorder other than CP